Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.31 | 7e-07 |